According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM ) is ยฃ0.47 Billion. an increase over the revenue in the year 2022 that were of ยฃ0.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | ยฃ0.47 B | 1.83% |
2022 | ยฃ0.47 B | 12.21% |
2021 | ยฃ0.41 B | -0.62% |
2020 | ยฃ0.42 B | -14.78% |
2019 | ยฃ0.49 B | -5.45% |
2018 | ยฃ0.52 B | 3.68% |
2017 | ยฃ0.50 B | -34.22% |
2016 | ยฃ0.76 B | 22.45% |
2015 | ยฃ0.62 B | 21.21% |
2014 | ยฃ0.51 B | 15.82% |
2013 | ยฃ0.44 B | 10.97% |
2012 | ยฃ0.40 B | 23.8% |
2011 | ยฃ0.32 B | 28.14% |
2010 | ยฃ0.25 B | 14.87% |
2009 | ยฃ0.22 B | |
2005 | ยฃ0.17 B | 18.37% |
2004 | ยฃ0.14 B | -16.08% |
2003 | ยฃ0.17 B | 33.64% |
2002 | ยฃ0.13 B | 27.44% |
2001 | ยฃ0.10 B | 48.89% |
2000 | ยฃ69.54 M | 34.12% |
1999 | ยฃ51.85 M | 29.27% |
1998 | ยฃ40.11 M | 7.85% |
1997 | ยฃ37.19 M | 12.72% |
1996 | ยฃ32.99 M |